Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings ROA 2010-2023 | CPHI

Current and historical return on assets (ROA) values for China Pharma Holdings (CPHI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
  
China Pharma Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2023-12-31 $-0.00B $0.02B -18.75%
2023-09-30 $-0.00B $0.02B -18.18%
2023-06-30 $-0.00B $0.02B -17.91%
2023-03-31 $-0.00B $0.02B -17.39%
2022-12-31 $-0.00B $0.02B -21.92%
2022-09-30 $-0.00B $0.02B -20.51%
2022-06-30 $-0.00B $0.02B -20.00%
2022-03-31 $-0.00B $0.02B -19.51%
2021-12-31 $-0.00B $0.02B -19.75%
2021-09-30 $-0.00B $0.02B -20.25%
2021-06-30 $-0.00B $0.02B -19.51%
2021-03-31 $-0.00B $0.02B -14.12%
2020-12-31 $-0.00B $0.02B -13.79%
2020-09-30 $-0.02B $0.02B -95.45%
2020-06-30 $-0.02B $0.02B -78.50%
2020-03-31 $-0.02B $0.02B -69.29%
2019-12-31 $-0.02B $0.02B -56.00%
2019-09-30 $-0.01B $0.04B -23.12%
2019-06-30 $-0.01B $0.04B -23.66%
2019-03-31 $-0.01B $0.05B -21.89%
2018-12-31 $-0.01B $0.05B -20.18%
2018-09-30 $-0.02B $0.05B -29.18%
2018-06-30 $-0.02B $0.06B -26.67%
2018-03-31 $-0.02B $0.06B -26.28%
2017-12-31 $-0.02B $0.06B -26.21%
2017-09-30 $-0.01B $0.08B -10.36%
2017-06-30 $-0.01B $0.08B -9.97%
2017-03-31 $-0.01B $0.08B -9.52%
2016-12-31 $-0.01B $0.08B -10.14%
2016-09-30 $-0.02B $0.09B -22.52%
2016-06-30 $-0.02B $0.09B -16.20%
2016-03-31 $-0.01B $0.10B -12.26%
2015-12-31 $-0.02B $0.10B -13.48%
2015-09-30 $-0.02B $0.11B -18.76%
2015-06-30 $-0.03B $0.12B -24.75%
2015-03-31 $-0.04B $0.12B -31.18%
2014-12-31 $-0.04B $0.12B -27.76%
2014-09-30 $-0.03B $0.14B -18.03%
2014-06-30 $-0.02B $0.15B -14.84%
2014-03-31 $-0.02B $0.15B -11.37%
2013-12-31 $-0.02B $0.16B -11.91%
2013-09-30 $-0.01B $0.16B -6.22%
2013-06-30 $-0.01B $0.16B -4.33%
2013-03-31 $-0.00B $0.16B -0.61%
2012-12-31 $0.01B $0.16B 3.04%
2012-09-30 $0.01B $0.17B 6.14%
2012-06-30 $0.01B $0.17B 8.81%
2012-03-31 $0.02B $0.16B 11.07%
2011-12-31 $0.02B $0.16B 12.95%
2011-09-30 $0.02B $0.15B 15.63%
2011-06-30 $0.02B $0.14B 17.23%
2011-03-31 $0.02B $0.14B 18.93%
2010-12-31 $0.02B $0.13B 20.08%
2010-09-30 $0.02B $0.12B 17.90%
2010-06-30 $0.02B $0.12B 20.00%
2010-03-31 $0.02B $0.11B 19.49%
2009-12-31 $0.02B $0.10B 19.89%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.328B 5.17
Dr Reddy's Laboratories (RDY) India $11.833B 18.71
Aspen Pharmacare (APNHY) South Africa $5.172B 0.00
BridgeBio Pharma (BBIO) United States $4.387B 0.00
Bausch Health Cos (BHC) Canada $3.143B 2.45
Amphastar Pharmaceuticals (AMPH) United States $1.889B 12.93
Supernus Pharmaceuticals (SUPN) United States $1.580B 0.00
Taysha Gene Therapies (TSHA) United States $0.451B 0.00
Generation Bio (GBIO) United States $0.185B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.061B 0.00
Acasti Pharma (ACST) Canada $0.029B 0.00
Sol-Gel Technologies (SLGL) Israel $0.025B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00